Superbugs Rising: The Antimicrobial Resistance Threat

Common bacterial infections are mutating to survive our best drugs. Antimicrobial resistance is turning easily treatable illnesses into severe medical threats. The global medical community is now racing to fund and develop new antibiotics before standard surgeries and medical treatments become too dangerous to perform.

Understanding the Scale of Antimicrobial Resistance

In 2019, the World Health Organization reported that antimicrobial resistance directly caused 1.27 million deaths worldwide. If current trends continue without intervention, the United Nations Environment Programme estimates that up to 10 million people could die annually from drug-resistant infections by the year 2050. In the United States alone, the Centers for Disease Control and Prevention notes that more than 2.8 million antimicrobial-resistant infections occur every single year.

This rapid rise in resistance means that simple procedures carry much higher risks. Routine knee replacements, emergency C-sections, and standard chemotherapy all rely on effective antibiotics to prevent post-operative infections. Without reliable drugs, modern medicine could easily slip back into a time where minor cuts or basic surgeries become fatal.

The Most Dangerous Superbugs Right Now

Not all bacteria pose the same level of risk. The medical community is tracking several specific pathogens that consistently defeat standard drug treatments.

Methicillin-resistant Staphylococcus aureus (MRSA): This well-known superbug causes severe skin infections, pneumonia, and bloodstream infections. It frequently spreads in healthcare settings and nursing homes.
Carbapenem-resistant Enterobacteriaceae (CRE): Health officials frequently refer to CRE as “nightmare bacteria.” These germs have high levels of resistance to last-resort antibiotics. The CDC reports that up to half of patients who contract bloodstream infections from CRE die.
Candida auris: This drug-resistant fungus is spreading rapidly through hospitals. It causes severe infections and is incredibly difficult to eradicate from hospital surfaces using standard cleaning supplies.
Drug-resistant Neisseria gonorrhoeae: The bacteria that causes gonorrhea has developed resistance to nearly every drug used to treat it. Doctors in the United States are now down to just one recommended highly effective treatment option, which is an injection of ceftriaxone.

The Broken Antibiotic Market

You might wonder why pharmaceutical companies are not simply inventing new drugs to combat these threats. The problem comes down to basic economics. Developing a new drug costs an average of $1 billion and takes 10 to 15 years of rigorous clinical trials.

Once a new and powerful antibiotic is approved, public health protocols instruct doctors to hold it in reserve. They only prescribe it for the absolute worst-case scenarios to prevent bacteria from adapting to the new drug. Because the medication sits on a hospital shelf instead of being sold daily to millions of people, the pharmaceutical company struggles to make back its research and development costs. Many smaller biotech companies, like Achaogen and Melinta Therapeutics, successfully developed life-saving antibiotics in the late 2010s only to file for bankruptcy shortly after their drugs were approved by the FDA.

The Urgent Push for New Treatments

Governments and private organizations are creating new financial models to fix this broken pipeline and bring new treatments to the public.

The AMR Action Fund: In 2020, over 20 major pharmaceutical companies (including Pfizer, Eli Lilly, and Johnson & Johnson) pledged nearly $1 billion to create this fund. Their specific goal is to bring two to four new antimicrobial treatments to patients by the year 2030.
The PASTEUR Act: This proposed legislation in the US Congress would change how the government buys antibiotics. Instead of paying per pill, the government would pay a fixed subscription fee to drug manufacturers. This guarantees a return on investment for the drugmaker, even if doctors correctly use the antibiotic very rarely.
Recent FDA Approvals: There is some recent progress in the laboratory. In May 2023, the FDA approved Xacduro (sulbactam-durlobactam) to treat hospital-acquired bacterial pneumonia caused by Acinetobacter baumannii, a notorious and deadly superbug.

Beyond Traditional Antibiotics

Scientists are also looking outside standard chemical drugs for biological solutions to kill resistant bacteria.

Phage Therapy: Bacteriophages are naturally occurring viruses that hunt and kill specific bacteria without harming human cells. Researchers at the University of California San Diego are currently running clinical trials to see if phage therapy can treat patients with severe superbug infections when all traditional antibiotics fail.
Monoclonal Antibodies: Similar to the treatments developed for COVID-19, laboratory-made antibodies are being tested to target and neutralize specific bacterial toxins in the bloodstream.
CRISPR Technology: Genetic engineering tools are being explored as a way to selectively cut the DNA of harmful bacteria without wiping out the helpful bacteria in a patient’s digestive system.

Everyday Actions to Slow the Spread

While researchers work on new drugs, public health officials urge everyday citizens to help slow the mutation of these dangerous bacteria.

Never demand antibiotics for viral infections. Antibiotics do not cure colds, the flu, or most sore throats. Taking them for viruses only kills your good bacteria and gives dangerous bacteria a chance to adapt.
Finish your prescription. If your doctor prescribes a seven-day course of amoxicillin, take it for the full seven days. Stopping after three days because you feel better leaves the strongest bacteria alive to multiply.
Stay updated on vaccines. Vaccinations for illnesses like the flu, COVID-19, and pneumococcal pneumonia prevent infections from happening in the first place. This reduces the overall need for doctors to prescribe antibiotics.
Practice safe food handling. The agricultural industry’s use of antibiotics in livestock contributes heavily to global resistance. Cooking meat thoroughly and washing your hands after handling raw meat helps prevent you from ingesting resistant bacteria.

Frequently Asked Questions

What is a superbug? A superbug is a strain of bacteria, virus, parasite, or fungus that has developed resistance to the medications normally used to destroy it. Because the standard drugs no longer work, the infections are much harder to treat.

How do bacteria become resistant? Bacteria naturally mutate over time. When exposed to an antibiotic, the weak bacteria die off quickly. However, bacteria with random protective mutations survive the medication. These survivors then multiply, creating a new generation of completely drug-resistant bacteria.

Are there any new antibiotics coming out soon? Yes, but the pipeline is moving slowly. The World Health Organization currently tracks about 40 to 50 antibacterial agents in clinical development worldwide. However, based on historical data, only a small fraction of these will successfully pass all trial phases to reach the public market.